SPDR SSgA多资产实际回报ETF RLY 深 沪
等待开盘 07-18 09:30:00 美东时间
29.4591
+0.079
+0.27%
华盛通- 最 高29.47
- 今 开29.33
- 成交量 5.74万股
- 最 低 29.2967
- 昨 收 29.38
- 总市值 5.05亿
- 52周最高 30.04
- 市盈率 静 --
- 换手率 0.34%
- 52周最低 25.3794
- 委 比 76.92%
- 总股本 1713.00万
- 历史最高 30.04
- 量 比 0.61
- 振 幅 0.59%
- 历史最低 7.013
- 每 手 1
- 风险率 0.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多WEIS MARKETS ANNOUNCES QUARTERLY DIVIDEND
SUNBURY, Pa., July 17, 2025 /PRNewswire/ -- Weis Markets, Inc.'s (NYSE: WMK) Board of Directors today declared a quarterly dividend of $0.34 per share to shareholders of record as of July 28...
今天 04:45
KalVista gets UK nod for Ekterly
KalVista Pharmaceuticals (NASDAQ:KALV) said that the UK health regulator has granted marketing authorization for Ekterly (sebetralstat), a plasma inhibitor, to treat hereditary angioedema attacks in p...
07-16 04:44
Washington Trust donates 1,600 personal hygiene items to Amenity Aid
Bank collected donations during free document shredding event for community WESTERLY, R.I., July 15, 2025 /PRNewswire/ -- Washington Trust recently collected and donated 1,667 personal hygie...
07-15 23:26
玫瑰岛北交所IPO，聚焦定制家居产品，净利润逐年下滑
格隆汇获悉，近日，广东玫瑰岛家居股份有限公司（简称“玫瑰岛”）提交了招股说明书申报稿，拟于北京证券交易所上市，保荐人为国投证券。 玫瑰岛注册地为广东省中山市，公...
07-15 11:29
VULCAN DECLARES QUARTERLY DIVIDEND ON COMMON STOCK
BIRMINGHAM, Ala., July 11, 2025 /PRNewswire/ -- The Board of Directors of Vulcan Materials Company (NYSE: VMC) today declared a quarterly cash dividend of $0.49 per share on its common stock...
07-12 04:30
KalVista Pharmaceuticals: EKTERLY Launch and Financial Update
KalVista Pharmaceuticals, Inc. ( ($KALV) ) has released its Q4 earnings. Here i...
07-11 11:53
KalVista Pharmaceuticals GAAP EPS of -$3.69
KalVista Pharmaceuticals press release (NASDAQ:KALV): FY GAAP EPS of -$3.69. $220.6M in cash, providing runway into 2027 More on KalVista Pharmaceuticals KalVista: FDA Approval Of EKTERLY As Oral On-D...
07-10 19:01
KalVista Pharmaceuticals Gains FDA Approval for EKTERLY®
KalVista Pharmaceuticals ( ($KALV) ) has shared an update. On July 7, 2025, Kal...
07-07 20:59
KalVista Wins FDA Nod for EKTERLY, A New Pill to Treat Sudden HAE Attacks
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel plasma kallikrein inhibitor, for the treatment of acute
07-07 18:32
SM ENERGY DECLARES QUARTERLY CASH DIVIDEND
DENVER, June 26, 2025 /PRNewswire/ -- SM Energy Company (NYSE: SM) today announces that its Board of Directors approved the quarterly cash dividend of $0.20 per share of common stock outstan...
06-27 04:15
